𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

✍ Scribed by Paul L. Nguyen; Ming-Hui Chen; Clair J. Beard; W. Warren Suh; Toni K. Choueiri; Jason A. Efstathiou; Karen E. Hoffman; Marian Loffredo; Philip W. Kantoff; Anthony V. D'Amico


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
156 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Influence of body mass index on prostate
✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio

Patient selection, cancer control, and c
✍ Paul L. Nguyen; Anthony V. D'Amico; Andrew K. Lee; W. Warren Suh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract Among men who experience prostate‐specific antigen (PSA) failure after external beam radiation or brachytherapy (RT), many will harbor occult micrometastases; however, a significant minority will have a true local‐only failure and, thus, potentially may benefit from a salvage local ther

The percentage of prostate needle biopsy
✍ Stephen J. Freedland; William J. Aronson; Martha K. Terris; Christopher J. Kane; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Background: The authors previously found that, although the total percentage of prostate needle biopsy cores with carcinoma was a significant predictor of prostate specific antigen (psa) failure among men undergoing radical prostatectomy (rp), there was a trend toward a lower risk of recurrence